review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1089-3261(02)00052-1 |
P8608 | Fatcat ID | release_tm7pl6bvajcszcwojho34lauhm |
P698 | PubMed publication ID | 12516200 |
P2093 | author name string | Robert B Zurier | |
Nancy J Walker | |||
P2860 | cites work | Still's disease in the adult | Q24514809 |
Sulfasalazine-induced fulminant hepatic failure | Q28327415 | ||
Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis | Q33552131 | ||
Pyrophosphate arthropathy: a study of metabolic associations and laboratory data | Q33553747 | ||
Hepatic function in ankylosing spondylitis | Q33554742 | ||
Increased serum alkaline phosphatase activity in ankylosing spondylitis | Q33554759 | ||
Liver disease in twins with Felty's syndrome | Q33566214 | ||
Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? | Q33580118 | ||
Relation between infection and autoimmunity in mixed cryoglobulinemia | Q33824793 | ||
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group | Q33885648 | ||
Gastrointestinal manifestations of scleroderma | Q34487889 | ||
Inflammation-mediated rheumatic diseases and atherosclerosis | Q35549285 | ||
Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients | Q35549891 | ||
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease | Q37624998 | ||
Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules | Q37928516 | ||
The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugs. | Q38509741 | ||
Epidemiology of Systemic Sclerosis (Scleroderma) | Q39335161 | ||
Effect of an intravenously administered bile acid (chenodeoxycholic acid) on rheumatoid arthritis | Q39590067 | ||
Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance | Q39632711 | ||
Hepatotoxicity following the therapeutic use of antipyretic analgesics | Q40165243 | ||
Assessment of hepatic function with xenobiotics | Q40377454 | ||
Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence. | Q40385238 | ||
Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs | Q40567553 | ||
Hepatic toxicity of antirheumatic drugs | Q40804142 | ||
Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis | Q40886002 | ||
Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention | Q41156662 | ||
Proceedings: Liver function tests and liver biopsies in patients with rheumatoid arthritis | Q41328522 | ||
Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials | Q41921005 | ||
Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy | Q41921017 | ||
Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples | Q42203139 | ||
Combined hepatotoxicity and neurotoxicity following sulphasalazine administration | Q42241538 | ||
Serum alkaline phosphatase in ankylosing spondylitis | Q42706417 | ||
The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 | ||
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. | Q45746740 | ||
Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha | Q45758150 | ||
Hepatic safety of two analgesics used over the counter: Ibuprofen and aspirin | Q52566030 | ||
Haematology and biochemistry of ankylosing spondylitis. | Q53822206 | ||
Therapeutic Effect of Induced Jaundice in Rheumatoid Arthritis | Q55118476 | ||
THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODY | Q59032616 | ||
HLA DQα and DQβ restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis | Q62733787 | ||
Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 | ||
Ulcer complications and nonsteroidal anti-inflammatory drugs | Q68281422 | ||
Renal insufficiency associated with nonsteroidal anti-inflammatory agents | Q70606793 | ||
Primary biliary cirrhosis | Q71742524 | ||
Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome | Q71781429 | ||
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology | Q72296676 | ||
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors | Q72747718 | ||
Hereditary hemochromatosis: a prevalent disorder of iron metabolism with an elusive etiology | Q72760666 | ||
Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone | Q77483123 | ||
Rheumatologic manifestations of gastrointestinal diseases | Q77803126 | ||
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis | Q77993297 | ||
P433 | issue | 4 | |
P304 | page(s) | 933-946 | |
P577 | publication date | 2002-11-01 | |
P1433 | published in | Clinics in liver disease | Q26842322 |
P1476 | title | Liver abnormalities in rheumatic diseases | |
P478 | volume | 6 |
Q41837394 | A case of primary biliary cirrhosis in a patient with rheumatoid arthritis |
Q46691712 | Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage. |
Q24814590 | Idiopathic portal hypertension complicating systemic sclerosis: a case report |
Q33412732 | Life-threatening complications of adult-onset Still's disease |
Q37670283 | Liver involvement in patients with systemic autoimmune diseases |
Q26770595 | Occult HCV Infection: The Current State of Knowledge |
Q37951386 | Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review |
Q46685913 | Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study |
Q84600226 | [Systemic sclerosis and the gastrointestinal tract. Diagnostic and therapeutic approach] |
Search more.